Live Breaking News & Updates on White Research Institute|Page 2

Stay updated with breaking news from White research institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SGLT-2 inhibitors show mixed results after heart attack

SGLT-2 inhibitors show mixed results after heart attack
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Mississippi , Javed Butler , Baylor Scott , American College Of Cardiology Annual Scientific Session , White Research Institute , American College , Annual Scientific , New England Journal , Acute Myocardial Infarction ,

EMPACT-MI Trial Outcomes Reported at ACC.24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24, being held in Atlanta, GA. ....

United States , University Of Mississippi , Baylor Scott , Javed Butler , Eli Lilly , White Research Institute , Boehringer Ingelheim , American College Of Cardiology Annual Scientific Session , American College , Annual Scientific , New England Journal , After Acute Myocardial Infarction ,

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack ....

United States , University Of Mississippi , Javed Butler , Baylor Scott , Eli Lilly , American College Of Cardiology Annual Scientific Session , White Research Institute , Boehringer Ingelheim , American College , Annual Scientific , New England Journal , After Acute Myocardial Infarction ,

Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitor

Yet empagliflozin gets a boost from a lower risk of total HF events in EMPACT-HF ....

United States , Baylor Scott , James Januzzi Jr , Patrick Ogara , Javed Butler , Nicole Lou , White Research Institute , American College Of Cardiology , Harvard Medical School , American College , New England Journal , Massachusetts General Hospital , Medpage Today , England Journal , Englj Med ,

Empagliflozin Misses Primary Endpoint in Post-MI Patient Population, EMPACT-MI Trial

Results of EMPACT-MI suggest use of empagliflozin was not associated with a statistically significant reduction in a composite of death and heart failure hospitalization. ....

United States , Baylor Scott , Javed Butler , American College Of Cardiology , Institute Javed Butler , University Of Mississippi , American Heart Association , White Research Institute , American College , Annual Scientific Session , Dont Miss , Confidence Interval , After Acute Myocardial Infarction , Results Of The , Annual Scientific , Myocardial Infarction , Redefining Cardiometabolic , Show Mixed Results After Heart ,